HTLV gp21

HTLV gp21 Full Name

Human T-lymphotropic virus Glycoprotein 21

HTLV gp21 Introduction

Human T-cell Leukemia Virus Glycoprotein 21 (HTLV gp21), also formally referred to as the transmembrane subunit (TM) of the HTLV envelope complex, is a crucial viral structural protein. It is encoded by the viral env gene and is synthesized as a precursor glycoprotein (gp62) that is post-translationally cleaved by a cellular protease to generate the mature surface subunit (gp46, SU) and the transmembrane gp21 (TM). The gp21 protein contains several key domains: an N-terminal hydrophobic fusion peptide, a central immunosuppressive domain that may modulate host immune responses, and a C-terminal transmembrane anchor. It remains non-covalently associated with the surface subunit (gp46) on the viral envelope, forming the functional spike complex essential for viral entry. Its structural stability and role in membrane fusion make it a critical component of the viral life cycle.

Figure 1. Human T-lymphotrophic virus type-1 (HTLV-1) genome, mRNA, and proteins.(Source:Lairmore M D, 2011)

Mechanism of Action in Viral Entry and Membrane Fusion
The primary function of gp21 is to mediate the fusion of the viral envelope with the host cell membrane, a critical step for viral entry. The process is initiated when the associated surface subunit (gp46) binds to specific host receptors, notably GLUT1, neuropilin-1 (NRP1), and heparan sulfate proteoglycans on target cells (primarily CD4+ T lymphocytes). This binding triggers conformational changes in the envelope complex, leading to the insertion of gp21's hydrophobic fusion peptide into the host cell membrane. Subsequently, gp21 undergoes a dramatic refolding event, forming a stable six-helix bundle structure that brings the viral and cellular membranes into close proximity, thereby driving membrane fusion and the release of the viral core into the cytoplasm. This irreversible, fusogenic conformation is the execution point of viral entry.

Diagnostic and Vaccine Development Significance
Due to its high immunogenicity and conservation among HTLV-1 strains, gp21 is a major target for the host's humoral immune response. Antibodies against gp21 are reliably detected in infected individuals, making specific epitopes on gp21 valuable components of serological diagnostic assays (e.g., Western Blot, line immunoassays) used to confirm HTLV-1/2 infection. In vaccine research, gp21 presents both an opportunity and a challenge. While it is a logical target for designing vaccines aimed at blocking membrane fusion and neutralizing the virus, its immunosuppressive domain and the complexity of the fusion mechanism have posed significant hurdles. Strategies have included designing recombinant proteins or peptides that mimic its pre-fusion state or the six-helix bundle to elicit neutralizing antibodies.

Alternate Names for HTLV gp21

HTLV-1; gp21; gp46

• 1.Lairmore M D, Anupam R, Bowden N. Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses, 2011, 3(7): 1131.